Search - tctmd.com

Displaying 381 - 400 of 900

Sort: Relevancy | Date

News Daily News

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Michael O'Riordan

November 05, 2019

News Daily News

Inequities Exist in ED Triage of Heart Failure Patients—With Repercussions

Caitlin E. Cox

October 30, 2019

News Daily News

Editorial Balance: Men More Likely Than Women to Author Invited Commentaries

Yael L. Maxwell

October 24, 2019

News Daily News

Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes

L.A. McKeown

October 21, 2019

News Daily News

CMS Cuts to Office-Based Noninvasive Cardiac Tests Are Driving Costs Higher

L.A. McKeown

October 17, 2019

News Daily News

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Michael O'Riordan

October 09, 2019

News Conference News TCT 2019

Portico Noninferior to Commercial TAVR Valves in IDE Study

Caitlin E. Cox

September 27, 2019

News Conference News TCT 2019

Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients

Yael L. Maxwell

September 27, 2019

News Conference News TCT 2019

Learning Curve Exists for MitraClip, Volume-Outcomes Data Hint

Todd Neale

September 27, 2019

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

News

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

Michael O'Riordan

September 24, 2019

News Daily News

Surgical Bailout Rarely Needed Though Can Save Lives: TVT Registry

Yael L. Maxwell

September 18, 2019

News Daily News

High-Sensitivity Troponin T May Offer Glimpse Into Future HF Risk: ARIC Analysis

L.A. McKeown

September 13, 2019

News Conference News ESC 2019

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

Caitlin E. Cox

September 06, 2019

News Conference News ESC 2019

DAPA-HF Details: Dapagliflozin Slashes HF Outcomes, Even in Nondiabetics

Shelley Wood

September 01, 2019

News Conference News ESC 2019

Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS

Michael O'Riordan

September 01, 2019

News Conference News ESC 2019

PARAGON-HF Misses Primary Endpoint, but Hints of Benefit Seen

Todd Neale

September 01, 2019

News Conference News ESC 2019

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

Shelley Wood

August 31, 2019

News Daily News

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

Michael O'Riordan

August 22, 2019

News Daily News

PET May Be Able to Pinpoint PAD Patients at Risk of Restenosis

Caitlin E. Cox

August 15, 2019

Advertisement

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Inequities Exist in ED Triage of Heart Failure Patients—With Repercussions

Editorial Balance: Men More Likely Than Women to Author Invited Commentaries

Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes

CMS Cuts to Office-Based Noninvasive Cardiac Tests Are Driving Costs Higher

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Portico Noninferior to Commercial TAVR Valves in IDE Study

Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients

Learning Curve Exists for MitraClip, Volume-Outcomes Data Hint

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

Surgical Bailout Rarely Needed Though Can Save Lives: TVT Registry

High-Sensitivity Troponin T May Offer Glimpse Into Future HF Risk: ARIC Analysis

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

DAPA-HF Details: Dapagliflozin Slashes HF Outcomes, Even in Nondiabetics

Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS

PARAGON-HF Misses Primary Endpoint, but Hints of Benefit Seen

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

PET May Be Able to Pinpoint PAD Patients at Risk of Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content